Abstract
Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Current Signal Transduction Therapy
Title:Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines
Volume: 8 Issue: 2
Author(s): Judit Molnar, Imre Ocsovszki, Laszlo Puskas, Tannaz Ghane, Judit Hohmann and István Zupko
Affiliation:
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Abstract: Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Export Options
About this article
Cite this article as:
Molnar Judit, Ocsovszki Imre, Puskas Laszlo, Ghane Tannaz, Hohmann Judit and Zupko István, Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines, Current Signal Transduction Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/15743624113086660006
DOI https://dx.doi.org/10.2174/15743624113086660006 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Current Alzheimer Research Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Protein & Peptide Letters Biodistribution of LV-TSTA Transduced Rat Bone Marrow Cells Used for “Ex-vivo” Regional Gene Therapy for Bone Repair
Current Gene Therapy An Effective Vaccination Approach Augments Anti-HIV Systemic and Vaginal Immunity in Mice with Decreased HIV-1 Susceptible α4β7high CD4+ T Cells
Current HIV Research Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Jatropha curcas: From Biodiesel Generation to Medicinal Applications
Recent Patents on Biotechnology DNA Secondary Structure at Chromosomal Fragile Sites in Human Disease
Current Genomics Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Tissue Fatty Acid Profile is Differently Modulated from Olive Oil and Omega-3 Polyunsaturated Fatty Acids in ApcMin/+ Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenomics of Non-Small Cell Lung Cancer
Current Pharmacogenomics Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin
Current Gene Therapy Translational Research of Photodynamic Therapy with Acridine Orange which Targets Cancer Acidity
Current Pharmaceutical Design Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
Current Chemical Biology An Overview of HDAC Inhibitors and their Synthetic Routes
Current Topics in Medicinal Chemistry Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Management of Endometrial Cancer: A Review
Reviews on Recent Clinical Trials DLEU1: A Functional Long Noncoding RNA in Tumorigenesis
Current Pharmaceutical Design